Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3543 Safety of Lanreotide Autogel (LAN) 120 mg plus Metformin (MET) in patients with advanced, well-differentiated (WD) gastro-intestinal (GI) or lung neuroendocrine tumors (NETs) - A pilot, open-label, prospective study: The MetNET-2 Trial (NCT02823691)

Introduction: Preclinical and clinical evidence supports a potential role for MET as an antineoplastic agent in WD NETs.

Conference:

Presenting Author: Pusceddu S

Authors: Pusceddu S, Prinzi N, Corti F, Beninato T, Milione M,

Keywords: neuroendocrine tumor, metformin, somatostatin analogues,

#3364 Sporadic and MEN1-related gastrinoma and Zollinger Ellison syndrome: Differences in clinical manifestation and severity

Introduction: Zollinger-Ellison syndrome (ZES) associated with gastrinoma may be sporadic (Sp), but in 25% of the cases is part of the inherited multiple endocrine neoplasia 1 (MEN1) syndrome. Data comparing Sp and MEN1/ZES forms are scanty.

Conference:

Presenting Author: Rossi R

Authors: Massironi S, Rossi R, Eller-Vainicher C, Cavalcoli F, Ciafardini C,

Keywords: gastrinoma, zollinger ellison syndrome, multiple endocrine neoplasia 1 (MEN1) syndrome,

#3100 Update on incidence, prevalence, treatment and survival of patients with small bowel neuroendocrine neoplasms in The Netherlands

Introduction: Small bowel neuroendocrine neoplasms (SB-NEN) are a rare cancer with relatively high survival rates compared to other cancers. Population-based studies are ideal to study rare indolent disease.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Kaçmaz E, Farina Sarasqueta A, van Eeden S, Dreijerink K, Klümpen H,

Keywords: epidemiology, survival, treatment, small bowel, neuroendocrine neoplasm, population-based,

#46 Neuroendocrine markers are expressed in human mammary glands

Introduction: Regulatory peptides have previously been detected in epithelial cells of human mammary glands. As these peptides are produced by scattered neuroendocrine cells in the epithelium of other tissues the aim of this study was to investigate whether the mammary glands express molecular markers for neuroendocrine cells.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Grönberg M, Amini R, Stridsberg M, Janson E, Saras J,

Keywords: Breast; Chromogranin; Ghrelin; Obestatin; Secretogranin; Vesicular monoamine transporter,